Ann Arbor Firm's Technology Makes Vaccines More EffectiveNanoBio Corp. Tuesday said that it is presenting new data demonstrating positive pre-clinical results for its intramuscular respiratory syncytial virus vaccine at the National Foundation for Infectious Diseases 16th Annual Conference on Vaccine Research.

Watch & Listen LIVE